A blood test is the analysis of blood sample performed in a laboratory and the blood is usually taken from the vein in the arm through a needle, or through a finger prick to determine patient’s health status. Blood tests are very often used in health care to understand biochemical and physiological states, mineral content, pharmaceutical drug effectiveness, organ function, disease and also used in drug tests to detect drug abuse. Multiple tests for specific blood components are often grouped together into one test panel called as blood panel or blood work. The function of organs and how well a treatment is working can be determined by blood culture tests.Ìý
Highlights
The global Blood Testing market was valued at US$ 471.3 million in 2022 and is anticipated to reach US$ 529 million by 2029, witnessing a CAGR of 1.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Some major factors that have been anticipated to drive the market growth in the region include the presence of large patient population, continuously improving healthcare infrastructure coupled with the scope of expansion of clinical laboratories. Rapidly increasing elderly population will play a key role in driving the market growth in Japan as elderly population are more often undergo various blood tests. In Rest of the World (RoW) region, Latin America, Africa and Middle East are the major markets. Growing economy of Brazil, Mexico and South Africa is expected to be a prominent growth factor for blood testing market during upcoming years. Lacks of awareness and limited knowledge about advanced technology coupled with reluctance to adopt newer technology have been restraining the market growth in the region since long.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Testing.
The Blood Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann La Roche
Siemens Healthineers
Segment by Type
Glucose
Lipid
BUN
A1C
CRP
Vitamin D
ALT
AST
Thyroid Stimulating Hormone
Segment by Application
Hospitals
Clinic and Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Blood Testing Âé¶¹Ô´´ Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Glucose
1.2.3 Lipid
1.2.4 BUN
1.2.5 A1C
1.2.6 CRP
1.2.7 Vitamin D
1.2.8 ALT
1.2.9 AST
1.2.10 Thyroid Stimulating Hormone
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Blood Testing Âé¶¹Ô´´ Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinic and Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Testing Âé¶¹Ô´´ Perspective (2018-2029)
2.2 Blood Testing Growth Trends by Region
2.2.1 Global Blood Testing Âé¶¹Ô´´ Size by Region: 2018 VS 2022 VS 2029
2.2.2 Blood Testing Historic Âé¶¹Ô´´ Size by Region (2018-2023)
2.2.3 Blood Testing Forecasted Âé¶¹Ô´´ Size by Region (2024-2029)
2.3 Blood Testing Âé¶¹Ô´´ Dynamics
2.3.1 Blood Testing Industry Trends
2.3.2 Blood Testing Âé¶¹Ô´´ Drivers
2.3.3 Blood Testing Âé¶¹Ô´´ Challenges
2.3.4 Blood Testing Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Testing Players by Revenue
3.1.1 Global Top Blood Testing Players by Revenue (2018-2023)
3.1.2 Global Blood Testing Revenue Âé¶¹Ô´´ Share by Players (2018-2023)
3.2 Global Blood Testing Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Testing Revenue
3.4 Global Blood Testing Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Blood Testing Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Testing Revenue in 2022
3.5 Blood Testing Key Players Head office and Area Served
3.6 Key Players Blood Testing Product Solution and Service
3.7 Date of Enter into Blood Testing Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Testing Breakdown Data by Type
4.1 Global Blood Testing Historic Âé¶¹Ô´´ Size by Type (2018-2023)
4.2 Global Blood Testing Forecasted Âé¶¹Ô´´ Size by Type (2024-2029)
5 Blood Testing Breakdown Data by Application
5.1 Global Blood Testing Historic Âé¶¹Ô´´ Size by Application (2018-2023)
5.2 Global Blood Testing Forecasted Âé¶¹Ô´´ Size by Application (2024-2029)
6 North America
6.1 North America Blood Testing Âé¶¹Ô´´ Size (2018-2029)
6.2 North America Blood Testing Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Blood Testing Âé¶¹Ô´´ Size by Country (2018-2023)
6.4 North America Blood Testing Âé¶¹Ô´´ Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Testing Âé¶¹Ô´´ Size (2018-2029)
7.2 Europe Blood Testing Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Blood Testing Âé¶¹Ô´´ Size by Country (2018-2023)
7.4 Europe Blood Testing Âé¶¹Ô´´ Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Testing Âé¶¹Ô´´ Size (2018-2029)
8.2 Asia-Pacific Blood Testing Âé¶¹Ô´´ Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Blood Testing Âé¶¹Ô´´ Size by Region (2018-2023)
8.4 Asia-Pacific Blood Testing Âé¶¹Ô´´ Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Testing Âé¶¹Ô´´ Size (2018-2029)
9.2 Latin America Blood Testing Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Blood Testing Âé¶¹Ô´´ Size by Country (2018-2023)
9.4 Latin America Blood Testing Âé¶¹Ô´´ Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Testing Âé¶¹Ô´´ Size (2018-2029)
10.2 Middle East & Africa Blood Testing Âé¶¹Ô´´ Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Blood Testing Âé¶¹Ô´´ Size by Country (2018-2023)
10.4 Middle East & Africa Blood Testing Âé¶¹Ô´´ Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Blood Testing Introduction
11.1.4 Abbott Laboratories Revenue in Blood Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Blood Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Blood Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 F. Hoffmann La Roche
11.3.1 F. Hoffmann La Roche Company Detail
11.3.2 F. Hoffmann La Roche Business Overview
11.3.3 F. Hoffmann La Roche Blood Testing Introduction
11.3.4 F. Hoffmann La Roche Revenue in Blood Testing Business (2018-2023)
11.3.5 F. Hoffmann La Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Blood Testing Introduction
11.4.4 Siemens Healthineers Revenue in Blood Testing Business (2018-2023)
11.4.5 Siemens Healthineers Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann La Roche
Siemens Healthineers
Ìý
Ìý
*If Applicable.